Cargando…
Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma
BACKGROUND: The enhancer of zeste homolog 2 (EZH2) gene exerts oncogene-like activities and its (over)expression has been linked to several human malignancies. Here, we studied a possible association between EZH2 expression and prognosis in patients with renal cell carcinoma (RCC). METHODS: EZH2 pro...
Autores principales: | Wagener, Nina, Macher-Goeppinger, Stephan, Pritsch, Maria, Hüsing, Johannes, Hoppe-Seyler, Karin, Schirmacher, Peter, Pfitzenmaier, Jesco, Haferkamp, Axel, Hoppe-Seyler, Felix, Hohenfellner, Markus |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2958940/ https://www.ncbi.nlm.nih.gov/pubmed/20920340 http://dx.doi.org/10.1186/1471-2407-10-524 |
Ejemplares similares
-
EZH2 Depletion Blocks the Proliferation of Colon Cancer Cells
por: Fussbroich, Bettina, et al.
Publicado: (2011) -
Endogenous BTG2 expression stimulates migration of bladder cancer cells and correlates with poor clinical prognosis for bladder cancer patients
por: Wagener, N, et al.
Publicado: (2013) -
Expression of inhibitor of apoptosis protein Livin in renal cell carcinoma and non-tumorous adult kidney
por: Wagener, N, et al.
Publicado: (2007) -
PI3K/AKT/mTOR Signaling Regulates the Virus/Host Cell Crosstalk in HPV-Positive Cervical Cancer Cells
por: Bossler, Felicitas, et al.
Publicado: (2019) -
Enhancer of Zeste homolog 2 (EZH2) induces epithelial-mesenchymal transition in endometriosis
por: Zhang, Qi, et al.
Publicado: (2017)